» Articles » PMID: 31004139

The Kansas University DHA Outcomes Study (KUDOS) Clinical Trial: Long-term Behavioral Follow-up of the Effects of Prenatal DHA Supplementation

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2019 Apr 21
PMID 31004139
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Docosahexaenoic acid (DHA) is a long-chain polyunsaturated fatty acid that has been linked to improved vision and cognition in postnatal feeding studies and has been consistently associated with reduction of early preterm birth in prenatal supplementation trials. This is a report of the first long-term follow-up of infants from mothers receiving prenatal DHA supplementation in a US cohort.

Objective: Our objective was to evaluate the efficacy of the prenatal supplementation on both global and granular longitudinal assessments of cognitive and behavioral development.

Methods: In a randomized double-blind clinical trial, mothers received either 600 mg/d of DHA or a placebo beginning at 14.5 weeks of gestation and capsules were provided until delivery. Children from those pregnancies were followed by cognitive and behavioral assessments administered from 10 mo through 6 y of age. From 301 mothers in the initial study, ∼200 infants completed the longitudinal schedule.

Results: Although this intervention had been shown to reduce high-risk pregnancies and improve visual attention in infants during the first year, only a few positive long-term effects of prenatal DHA supplementation emerged from analyses of this follow-up. Increases in maternal blood DHA during pregnancy were related to verbal and full scale intelligence quotient (IQ) scores at 5 and 6 y, but these effects disappeared after controlling for SES. Maternal blood DHA concentrations at delivery were unrelated to outcomes, although maternal DHA at enrollment was related to productive vocabulary at 18 mo.

Conclusions: Although prenatal DHA supplementation substantially reduced early preterm birth and improved visual attention in infancy in this sample, no consistent long-term benefits were observed into childhood. Increases in maternal blood DHA concentration in pregnancy were related to higher IQs but this effect was confounded with SES and disappeared when SES was statistically controlled. This trial was registered at http://www.clinicaltrials.gov as NCT00266825 and NCT02487771.

Citing Articles

Maternal Obesity and Neurodevelopment of the Offspring.

Eleftheriades A, Koulouraki S, Belegrinos A, Eleftheriades M, Pervanidou P Nutrients. 2025; 17(5).

PMID: 40077761 PMC: 11901708. DOI: 10.3390/nu17050891.


Adaptive changes in multiple aspects of emotion regulation in the offspring of pregnant persons receiving a diet-and-exercise intervention relative to usual pregnancy care: a randomized controlled trial.

Krzeczkowski J, Mortaji N, Atkinson S, Schmidt L, Van Lieshout R Am J Clin Nutr. 2024; 121(1):50-59.

PMID: 39486684 PMC: 11747193. DOI: 10.1016/j.ajcnut.2024.10.022.


A co-ordinated transcriptional programme in the maternal liver supplies long chain polyunsaturated fatty acids to the conceptus using phospholipids.

Amarsi R, Furse S, Cleaton M, Maurel S, Mitchell A, Ferguson-Smith A Nat Commun. 2024; 15(1):6767.

PMID: 39117683 PMC: 11310303. DOI: 10.1038/s41467-024-51089-z.


Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?.

Amza M, Haj Hamoud B, Sima R, Dinu M, Gorecki G, Popescu M Biomedicines. 2024; 12(7).

PMID: 39062044 PMC: 11274850. DOI: 10.3390/biomedicines12071471.


A Systematic Review over the Effect of Early Infant Diet on Neurodevelopment: Insights from Neuroimaging.

Gilbreath D, Hagood D, Larson-Prior L Nutrients. 2024; 16(11).

PMID: 38892636 PMC: 11174660. DOI: 10.3390/nu16111703.


References
1.
Malcolm C, McCulloch D, Montgomery C, Shepherd A, Weaver L . Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed. 2003; 88(5):F383-90. PMC: 1721603. DOI: 10.1136/fn.88.5.f383. View

2.
Gould J, Smithers L, Makrides M . The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013; 97(3):531-44. DOI: 10.3945/ajcn.112.045781. View

3.
Carlson S, Ford A, Werkman S, Peeples J, Koo W . Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatr Res. 1996; 39(5):882-8. DOI: 10.1203/00006450-199605000-00024. View

4.
Hadders-Algra M, Bouwstra H, van Goor S, Dijck-Brouwer D, Muskiet F . Prenatal and early postnatal fatty acid status and neurodevelopmental outcome. J Perinat Med. 2007; 35 Suppl 1:S28-34. DOI: 10.1515/JPM.2007.034. View

5.
Clandinin M, Chappell J, Leong S, Heim T, Swyer P, Chance G . Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev. 1980; 4(2):131-8. DOI: 10.1016/0378-3782(80)90016-x. View